About the Gold Standard Time to Diagnosis programme

The Gold Standard Time to Diagnosis programme and Act on Axial SpA campaign is led by the National Axial Spondyloarthritis Society (NASS) in partnership with Norfolk & Norwich NHS Foundation Trust and RUH Bath NHS Foundation Trust and is funded by UCB.

UCB (www.ucbpharma.co.uk) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases.

The Gold Standard Time to Diagnosis programme is funded by UCB a sponsor of the project. UCB has no editorial control over the content or output of the programme.